Benson Investment Management Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-40,725
Closed -$3.54M 59
2020
Q3
$3.54M Buy
40,725
+105
+0.3% +$9.1K 2.27% 29
2020
Q2
$3.55M Buy
40,620
+115
+0.3% +$9.93K 2.45% 19
2020
Q1
$3.34M Buy
40,505
+645
+2% +$57.5K 2.68% 14
2019
Q4
$3.77M Hold
39,860
2.43% 21
2019
Q3
$3.46M Sell
39,860
-1,250
-3% -$112K 2.49% 19
2019
Q2
$3.75M Buy
41,110
+3,300
+9% +$279K 2.83% 11
2019
Q1
$3.26M Buy
+37,810
New +$3.04M 2.52% 18
2018
Q2
Sell
-11
Closed -$1K 79
2018
Q1
$1K Buy
+11
New +$837 ﹤0.01% 81
2017
Q4
Sell
-11
Closed -$1K 77
2017
Q3
$1K Hold
11
﹤0.01% 86
2017
Q2
$1K Hold
11
﹤0.01% 89
2017
Q1
$1K Buy
+11
New +$733 ﹤0.01% 90

Other funds holding NVS

Benson Investment Management Company's NVS Position: Q4 2020 in Review

Benson Investment Management Company sold out of Novartis (NVS) in Q4 2020, closing a stake of 40,725 shares — an estimated $3.54M sold.

Benson Investment Management Company first reported a position in NVS in Q1 2017 and held it in 11 quarters. The position peaked at $3.77M in Q4 2019. 1,177 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

  • Benson Investment Management Company reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
  • Benson Investment Management Company sold 40,725 Novartis shares in Q4 2020, an estimated $3.54M.
  • Benson Investment Management Company first reported a position in Novartis in Q1 2017 and held it in 11 quarters.
  • Benson Investment Management Company's Novartis position peaked at $3.77M in Q4 2019.
  • 1,177 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on Benson Investment Management Company's 13F filing for Q4 2020, filed 13 Jan 2021.